Trial: 202011125

Testing the immunologic effects of CDX-301 and CDX-1140 in resectable pancreatic cancer patients

Phase

II

Principal Investigator

Hawkins, William

Disease Site

Pancreas

Learn more about this study at: clinicaltrials.gov